Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Olympia Veterinary Cancer Center (OVCC) is a specialized veterinary oncology facility located in Olympia, Washington, dedicated to providing advanced cancer care for companion animals. Founded by board-certified oncologist Dr. Lisa Parshley and Dr. Tom Allen, the center offers a comprehensive range of services including chemotherapy, radiation therapy, immunotherapy, and specialized surgery. OVCC is distinguished by its active involvement in clinical research, having participated in pioneering trials for nanoparticle-based thermal ablation therapies in collaboration with Nanospectra Biosciences. In 2023, the center was acquired by BluePearl Pet Hospital, a national leader in specialty and emergency veterinary medicine. Following the acquisition, OVCC integrated its operations into a new, state-of-the-art BluePearl facility in Olympia to expand its reach and capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Olympia Veterinary Cancer Center.